Yuling Qiu
Impact in
- Drug Discovery top 5%
-
- Traditional Chinese Medicine Analysis
- Natural Compounds in Disease Treatment
- Medical Research and Treatments
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 12
- Co-authors
- Dexin Kong (34 shared papers)Shuangshuang Yin (15 shared papers)Ran Wang (24 shared papers)Kailong Wang (5 shared papers)Tao Wang (7 shared papers)Haiyang Yu (12 shared papers)Haiyang Yu (10 shared papers)Yiman Liu (7 shared papers)
- Journals
- BioMed Research International (4 papers)Oncotarget (3 papers)Biomedicine & Pharmacotherapy (3 papers)Frontiers in Oncology (2 papers)International Journal of Molecular Sciences (2 papers)
- Partner nations
- ChinaSouth KoreaHong Kong
In The Last Decade
Yuling Qiu
83 papers receiving 2.4k citations
Yuling Qiu's Hit Papers
Peers
Comparison fields: 5 of 101
- Drug Discovery 17
- Complementary and alternative medicine 279
- Cancer Research 234
- Pharmacology 212
- Molecular Biology 726
Countries citing papers authored by Yuling Qiu
This map shows the geographic impact of Yuling Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuling Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuling Qiu more than expected).
Fields of papers citing papers by Yuling Qiu
This network shows the impact of papers produced by Yuling Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuling Qiu. The network helps show where Yuling Qiu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuling Qiu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Anticancer activities of TCM and their active components against tumor metastasis Hit paper breakdown → | 2020 | 292 |
| 2 | 2020 | 193 | |
| 3 | 2019 | 150 | |
| 4 | 2016 | 139 | |
| 5 | 2016 | 137 | |
| 6 | 2022 | 85 | |
| 7 | 2017 | 75 | |
| 8 | 2012 | 72 | |
| 9 | 2014 | 51 | |
| 10 | Ferroptosis and pyroptosis are connected through autophagy: a new perspective of overcoming drug resistance Hit paper breakdown → | 2025 | 50 |
| 11 | 2021 | 48 | |
| 12 | 2015 | 41 | |
| 13 | 2016 | 40 | |
| 14 | 2018 | 40 | |
| 15 | 2011 | 34 | |
| 16 | 2018 | 34 | |
| 17 | 2018 | 33 | |
| 18 | 2019 | 33 | |
| 19 | 2024 | 33 | |
| 20 | 2012 | 32 |
About Yuling Qiu
Yuling Qiu is a scholar working on Cancer Research, Molecular Biology, Pharmacology, Oncology and Genetics, having authored 85 papers that have together received 2.4k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (12 papers), Healthcare and Venom Research (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Hemoglobinopathies and Related Disorders (6 papers), Venomous Animal Envenomation and Studies (6 papers), Immune cells in cancer (5 papers), Autophagy in Disease and Therapy (5 papers) and Natural Compounds in Disease Treatment (4 papers). The work is most often cited by research in Drug Discovery (17 citations), Complementary and alternative medicine (279 citations), Cancer Research (234 citations), Pharmacology (212 citations) and Molecular Biology (726 citations). Yuling Qiu has collaborated with scholars based in China, South Korea and Hong Kong. Frequent co-authors include Dexin Kong, Shuangshuang Yin, Ran Wang, Kailong Wang, Tao Wang, Haiyang Yu, Haiyang Yu, Yiman Liu, Yingying Shao and Xiaomei Bao. Their work appears in journals such as BioMed Research International, Oncotarget, Biomedicine & Pharmacotherapy, Frontiers in Oncology and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.